FTC, FDA to enhance antitrust oversight in biologics market


The Federal Trade Commission and Food and Drug Administration have signaled they will be increasing their oversight of any potential antitrust behavior in the biologics market.

lock iconTHIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.